NNI-351
NNI-351 bụ onye na-emechi ọnụ nke DYRK1A na neurogenesis enhancer bụ nke NeuroNascent, Inc. na-emepe emepe maka ọgwụgwọ nke Down syndrome, ịda mbà n'obi, na nsogbu nrụgide post-traumatic (PTSD).[1][2] N'ihe dị ka afọ 2017, ọ nọ na ọkwa mmepe nke izizi, ma ọ ka ga-aga n'ihu na nnwale ụlọ ọgwụ mmadụ.[1] Na Julaị 2022, FDA nyere NNI-351 ọkwa ọgwụ Orphan maka ọgwụgwọ ọrịa Fragile X.
Hụkwa[dezie | dezie ebe o si]
- Ndepụta antidepressants nyocha